Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

Cho EA, Moloney FJ, Cai H, Au-Yeung A, China C, Scolyer RA, Yosufi B, Raftery MJ, Deng JZ, Morton SW, Hammond PT, Arkenau HT, Damian DL, Francis DJ, Chesterman CN, Barnetson RS, Halliday GM, Khachigian LM.

Lancet. 2013 May 25;381(9880):1835-43. doi: 10.1016/S0140-6736(12)62166-7. Epub 2013 May 7.

2.

Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.

Patel R, Gao M, Ahmad I, Fleming J, Singh LB, Rai TS, McKie AB, Seywright M, Barnetson RJ, Edwards J, Sansom OJ, Leung HY.

J Clin Invest. 2013 Mar;123(3):1157-75. doi: 10.1172/JCI63672. Epub 2013 Feb 22.

3.

Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function.

Khachigian LM, Cai H, Moloney FJ, Parish CR, Chong BH, Stocker R, Barnetson RS, Halliday GM.

Oncotarget. 2012 Jun;3(6):594-5.

4.

DNAzyme targeting c-jun suppresses skin cancer growth.

Cai H, Santiago FS, Prado-Lourenco L, Wang B, Patrikakis M, Davenport MP, Maghzal GJ, Stocker R, Parish CR, Chong BH, Lieschke GJ, Wong TW, Chesterman CN, Francis DJ, Moloney FJ, Barnetson RS, Halliday GM, Khachigian LM.

Sci Transl Med. 2012 Jun 20;4(139):139ra82. doi: 10.1126/scitranslmed.3003960.

5.

HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer.

Ahmad I, Patel R, Singh LB, Nixon C, Seywright M, Barnetson RJ, Brunton VG, Muller WJ, Edwards J, Sansom OJ, Leung HY.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16392-7. doi: 10.1073/pnas.1101263108. Epub 2011 Sep 19.

6.

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.

Bock VL, Lyons JG, Huang XX, Jones AM, McDonald LA, Scolyer RA, Moloney FJ, Barnetson RS, Halliday GM.

Br J Dermatol. 2011 Jun;164(6):1221-7. doi: 10.1111/j.1365-2133.2011.10267.x. Epub 2011 May 13.

PMID:
21564052
7.

Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes.

Carvajal-Carmona LG, Cazier JB, Jones AM, Howarth K, Broderick P, Pittman A, Dobbins S, Tenesa A, Farrington S, Prendergast J, Theodoratou E, Barnetson R, Conti D, Newcomb P, Hopper JL, Jenkins MA, Gallinger S, Duggan DJ, Campbell H, Kerr D, Casey G, Houlston R, Dunlop M, Tomlinson I.

Hum Mol Genet. 2011 Jul 15;20(14):2879-88. doi: 10.1093/hmg/ddr190. Epub 2011 Apr 29.

8.

GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer.

Tan SS, Ahmad I, Bennett HL, Singh L, Nixon C, Seywright M, Barnetson RJ, Edwards J, Leung HY.

J Pathol. 2011 Jan;223(1):81-7. doi: 10.1002/path.2795. Epub 2010 Oct 28.

PMID:
21125667
9.

A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.

Theodoratou E, Campbell H, Tenesa A, Houlston R, Webb E, Lubbe S, Broderick P, Gallinger S, Croitoru EM, Jenkins MA, Win AK, Cleary SP, Koessler T, Pharoah PD, Küry S, Bézieau S, Buecher B, Ellis NA, Peterlongo P, Offit K, Aaltonen LA, Enholm S, Lindblom A, Zhou XL, Tomlinson IP, Moreno V, Blanco I, Capellà G, Barnetson R, Porteous ME, Dunlop MG, Farrington SM.

Br J Cancer. 2010 Dec 7;103(12):1875-84. doi: 10.1038/sj.bjc.6605966. Epub 2010 Nov 9.

10.

Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.

Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, Howarth K, Spain SL, Broderick P, Domingo E, Farrington S, Prendergast JG, Pittman AM, Theodoratou E, Smith CG, Olver B, Walther A, Barnetson RA, Churchman M, Jaeger EE, Penegar S, Barclay E, Martin L, Gorman M, Mager R, Johnstone E, Midgley R, Niittymäki I, Tuupanen S, Colley J, Idziaszczyk S; COGENT Consortium, Thomas HJ, Lucassen AM, Evans DG, Maher ER; CORGI Consortium; COIN Collaborative Group; COINB Collaborative Group, Maughan T, Dimas A, Dermitzakis E, Cazier JB, Aaltonen LA, Pharoah P, Kerr DJ, Carvajal-Carmona LG, Campbell H, Dunlop MG, Tomlinson IP.

Nat Genet. 2010 Nov;42(11):973-7. doi: 10.1038/ng.670. Epub 2010 Oct 24.

11.

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG.

Gut. 2010 Dec;59(12):1670-9. doi: 10.1136/gut.2009.203000. Epub 2010 Sep 15. Review.

PMID:
20844293
12.

Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis.

Tenesa A, Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, Porteous ME, Campbell H, Dunlop MG.

Clin Cancer Res. 2010 Jul 15;16(14):3754-9. doi: 10.1158/1078-0432.CCR-10-0439. Epub 2010 Jul 13.

13.

Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.

Wiltshire C, Singh BL, Stockley J, Fleming J, Doyle B, Barnetson R, Robson CN, Kozielski F, Leung HY.

Mol Cancer Ther. 2010 Jun;9(6):1730-9. doi: 10.1158/1535-7163.MCT-09-1103. Epub 2010 Jun 1.

14.

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.

Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt MT, Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S, Gibson LE, Tope WD.

Int J Dermatol. 2009 Nov;48(11):1236-45. doi: 10.1111/j.1365-4632.2008.04022.x.

PMID:
20064185
15.

Risks of Lynch syndrome cancers for MSH6 mutation carriers.

Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH; Dutch Lynch Syndrome Study Group, Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA.

J Natl Cancer Inst. 2010 Feb 3;102(3):193-201. doi: 10.1093/jnci/djp473. Epub 2009 Dec 22.

16.

Association between common mtDNA variants and all-cause or colorectal cancer mortality.

Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Campbell H, Tenesa A.

Carcinogenesis. 2010 Feb;31(2):296-301. doi: 10.1093/carcin/bgp237. Epub 2009 Nov 27.

PMID:
19945968
17.

The australasian society for dermatology research: a new player on the team.

Barnetson R, Halliday GM, Sinclair R.

J Invest Dermatol. 2009 Aug;129(8):1843-4. doi: 10.1038/jid.2009.189. No abstract available.

18.

Western lifestyle and increased prevalence of atopic diseases: an example from a small papua new guinean island.

Herbert OCh, Barnetson RS, Weninger W, Krämer U, Behrendt H, Ring J.

World Allergy Organ J. 2009 Jul;2(7):130-7. doi: 10.1097/WOX.0b013e3181accf27.

19.

Unusual presentation of Lynch Syndrome.

Yu VP, Novelli M, Payne SJ, Fisher S, Barnetson RA, Frayling IM, Barrett A, Goudie D, Ardern-Jones A, Eeles R, Shanley S.

Hered Cancer Clin Pract. 2009 Jun 3;7(1):12. doi: 10.1186/1897-4287-7-12.

20.

Breast cancer immunohistochemistry can be useful in triage of some HNPCC families.

Shanley S, Fung C, Milliken J, Leary J, Barnetson R, Schnitzler M, Kirk J.

Fam Cancer. 2009;8(3):251-5. doi: 10.1007/s10689-008-9226-4. Epub 2009 Jan 4.

PMID:
19123071
21.

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.

COGENT Study, Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S; Colorectal Cancer Association Study Consortium, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS; CoRGI Consortium, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG.

Nat Genet. 2008 Dec;40(12):1426-35. doi: 10.1038/ng.262. Epub 2008 Nov 16.

22.

Restoring TGFbeta function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation.

Warusavitarne J, McDougall F, de Silva K, Barnetson R, Messina M, Robinson BG, Schnitzler M.

Int J Colorectal Dis. 2009 Feb;24(2):139-44. doi: 10.1007/s00384-008-0606-x. Epub 2008 Nov 5.

PMID:
18985362
23.

Keratinizing squamous metaplasia of the bladder: a review.

Ahmad I, Barnetson RJ, Krishna NS.

Urol Int. 2008;81(3):247-51. doi: 10.1159/000151398. Epub 2008 Oct 16. Review.

24.

Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding.

Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Campbell H.

Int J Cancer. 2008 Nov 1;123(9):2170-9. doi: 10.1002/ijc.23769.

25.

Modification of the associations between lifestyle, dietary factors and colorectal cancer risk by APC variants.

Theodoratou E, Campbell H, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Farrington SM.

Carcinogenesis. 2008 Sep;29(9):1774-80. doi: 10.1093/carcin/bgn082. Epub 2008 Mar 28.

PMID:
18375958
26.

A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.

Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, Spain S, Lubbe S, Walther A, Sullivan K, Jaeger E, Fielding S, Rowan A, Vijayakrishnan J, Domingo E, Chandler I, Kemp Z, Qureshi M, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Penegar S, Barclay E, Wood W, Martin L, Gorman M, Thomas H, Peto J, Bishop DT, Gray R, Maher ER, Lucassen A, Kerr D, Evans DG; CORGI Consortium, Schafmayer C, Buch S, Völzke H, Hampe J, Schreiber S, John U, Koessler T, Pharoah P, van Wezel T, Morreau H, Wijnen JT, Hopper JL, Southey MC, Giles GG, Severi G, Castellví-Bel S, Ruiz-Ponte C, Carracedo A, Castells A; EPICOLON Consortium, Försti A, Hemminki K, Vodicka P, Naccarati A, Lipton L, Ho JW, Cheng KK, Sham PC, Luk J, Agúndez JA, Ladero JM, de la Hoya M, Caldés T, Niittymäki I, Tuupanen S, Karhu A, Aaltonen L, Cazier JB, Campbell H, Dunlop MG, Houlston RS.

Nat Genet. 2008 May;40(5):623-30. doi: 10.1038/ng.111. Epub 2008 Mar 30.

PMID:
18372905
27.

Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.

Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Semple C, Clark AJ, Reid FJ, Smith LA, Kavoussanakis K, Koessler T, Pharoah PD, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Schmidt CO, Hampe J, Chang-Claude J, Hoffmeister M, Brenner H, Wilkening S, Canzian F, Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson IP, Kemp Z, Howarth K, Carvajal-Carmona L, Webb E, Broderick P, Vijayakrishnan J, Houlston RS, Rennert G, Ballinger D, Rozek L, Gruber SB, Matsuda K, Kidokoro T, Nakamura Y, Zanke BW, Greenwood CM, Rangrej J, Kustra R, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG.

Nat Genet. 2008 May;40(5):631-7. doi: 10.1038/ng.133. Epub 2008 Mar 30.

28.

Dietary vitamin B6 intake and the risk of colorectal cancer.

Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Campbell H.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):171-82. doi: 10.1158/1055-9965.EPI-07-0621.

29.

Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer.

Barnetson RA, Cartwright N, van Vliet A, Haq N, Drew K, Farrington S, Williams N, Warner J, Campbell H, Porteous ME, Dunlop MG.

Hum Mutat. 2008 Mar;29(3):367-74.

PMID:
18033691
30.

Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer.

Barnetson RA, Devlin L, Miller J, Farrington SM, Slater S, Drake AC, Campbell H, Dunlop MG, Porteous ME.

Clin Genet. 2007 Dec;72(6):551-5. Epub 2007 Oct 22.

PMID:
17956577
31.

UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide.

Damian DL, Patterson CR, Stapelberg M, Park J, Barnetson RS, Halliday GM.

J Invest Dermatol. 2008 Feb;128(2):447-54. Epub 2007 Sep 20.

32.

Dietary fatty acids and colorectal cancer: a case-control study.

Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, Campbell H.

Am J Epidemiol. 2007 Jul 15;166(2):181-95. Epub 2007 May 9.

PMID:
17493949
33.

Dietary flavonoids and the risk of colorectal cancer.

Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, Campbell H.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):684-93.

34.

Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D.

Damian DL, Barnetson RS, Thompson JF.

J Cutan Med Surg. 2006 Jan-Feb;10(1):48-51.

PMID:
17241574
35.

Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans.

Howes RA, Halliday GM, Barnetson RS, Friedmann AC, Damian DL.

J Dermatol Sci. 2006 Nov;44(2):113-5. Epub 2006 Sep 14. No abstract available.

PMID:
16973333
36.

Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband.

Phan TA, Halliday GM, Barnetson RS, Damian DL.

Photodermatol Photoimmunol Photomed. 2006 Aug;22(4):174-80.

PMID:
16869864
37.

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.

Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG.

N Engl J Med. 2006 Jun 29;354(26):2751-63.

38.

Association of MUTYH and colorectal cancer.

Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington SM.

Br J Cancer. 2006 Jul 17;95(2):239-42. Epub 2006 Jun 27.

39.

Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression.

Zhang G, Luo X, Sumithran E, Pua VS, Barnetson RS, Halliday GM, Khachigian LM.

Oncogene. 2006 Nov 23;25(55):7260-6. Epub 2006 Jun 19.

PMID:
16785994
40.

[Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers.

Barnetson RS, Ooi TK, Zhuang L, Halliday GM, Reid CM, Walker PC, Humphrey SM, Kleinig MJ.

J Invest Dermatol. 2006 Aug;126(8):1869-78. Epub 2006 Jun 8.

41.

Recent developments in the treatment of adult atopic dermatitis.

Pua VS, Barnetson RS.

Australas J Dermatol. 2006 May;47(2):84-9. Review.

PMID:
16637800
42.

Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo.

Ibbotson SH, Jong C, Lesar A, Ferguson JS, Padgett M, O'Dwyer M, Barnetson R, Ferguson J.

Photodermatol Photoimmunol Photomed. 2006 Apr;22(2):105-10.

PMID:
16606416
43.
44.

Pravastatin-induced lichenoid drug eruption.

Pua VS, Scolyer RA, Barnetson RS.

Australas J Dermatol. 2006 Feb;47(1):57-9. Review.

PMID:
16405486
45.

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.

Ooi T, Barnetson RS, Zhuang L, McKane S, Lee JH, Slade HB, Halliday GM.

Br J Dermatol. 2006 Jan;154(1):72-8.

PMID:
16403097
46.
47.

Spectral and dose dependence of ultraviolet radiation-induced immunosuppression.

Phan TA, Halliday GM, Barnetson RS, Damian DL.

Front Biosci. 2006 Jan 1;11:394-411. Review.

PMID:
16146741
48.

Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.

Lowes MA, Turton JA, Krueger JG, Barnetson RS.

BMC Dermatol. 2005 Aug 18;5:9.

49.

Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans.

Kuchel JM, Barnetson RS, Halliday GM.

Photochem Photobiol Sci. 2005 Aug;4(8):577-82. Epub 2005 Jul 8.

PMID:
16052262
50.

Borderline lepromatous leprosy presenting as a single cutaneous plaque.

Armour KS, Scolyer RA, Barnetson RS.

Australas J Dermatol. 2005 Aug;46(3):181-3.

PMID:
16008652

Supplemental Content

Loading ...
Support Center